trial

Effect of High-Dose B-Complex Vitamins on the Symptoms of Schizophrenia

NCTId NCT00403247
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 50 (actual)
Sponsored by Nathan Kline Institute for Psychiatric Research
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
50 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Triple
Start
2004-07
Primary completion
—
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Capsule with folate, Vitamin B12 & pyridoxine

Sponsors

Nathan Kline Institute for Psychiatric ResearchLead Sponsor
Stanley Medical Research InstituteCollaborator

Investigators

1
William R. McFarlane, M.D.Principal Investigator

Sites

1 total
Orangeburg, United States

Facts & assertions

3 sourced
Enrollment
50
Phase
NA
Status
COMPLETED
relationships
The graph out of here
drug
Capsule with folate, Vitamin B12 & pyridoxine
drug
lead_sponsor
Nathan Kline Institute for Psychiatric Research
company
collaborator
Stanley Medical Research Institute
company
indication
Schizophrenia
indication
Schizoaffective Disorder
indication
Schizophrenia
indication
investigator
William R. McFarlane, M.D.
person